BMY - Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs 43rd Annual Global Healthcare Conference
Bristol-Myers Squibb Company (BMY) Goldman Sachs 43rd Annual Global Healthcare Conference June 15, 2022 12:20 ET CorporateParticipants Adam Lenkowsky - Senior Vice President and General Manager, U.S. Commercialization ConferenceCall Participants Chris Shibutani - Goldman Sachs Presentation Chris Shibutani Okay, good morning, everybody. This is the place to be obviously with Pfizer and now with Bristol. Thank you for staying with us during our Goldman Sachs Healthcare Conference. Excuse me for that. My name is Chris Shibutani. I am a member of the research team cover pharmaceuticals and biotechnology. We are thrilled to have Bristol Myers join us as well, when we launched our coverage there by recommendation and the stock has been amongst the most resilient in this environment, a lot of exciting fundamentals, very pleased that we could have with us a point person who I think can really give voice to many of the things that will move
For further details see:
Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs 43rd Annual Global Healthcare Conference